Aim Bulletin
Synnovia discovers non-material overstatement of revenues, reports strong growth
Industrial components manufacturer Synnovia recently discovered a non-material overstatement of revenues linked to its trading year ended 31 March 2018.
Mincon revenues soar as sales of own-brand products increase
Irish engineering group Mincon saw own-brand sales increase in the first quarter of its trading year, resulting in improved revenues for the group as a whole.
Verditek partners with Engenera to advance solar projects
Verditek on Thursday signed a framework agreement with Engenera Renewables to advance commercial opportunities and jointly provide end-to-end solar solutions to clients.
Scancell gets go-ahead for UK second phase trials of 'SCIB1'
Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of ‘SCIB1’ in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Water Intelligence anticipates H1 boost from North America contract wins
Water Intelligence on Thursday said it was optimistic for a "strong" first half of the year following contract wins in the US and Canada by its subsidiary, Water Intelligence International Limited (WII), including a contract in Flint, Michigan.
Allergy Therapeutics eyes 2020 start for hay fever inoculation trials
Commercial biotechnology company Allergy Therapeutics will kick off phase III trials of its short-course inoculation for grass pollen-induced hay fever in the second half of 2020 following a successful round of meetings with German and American regulatory bodies.
Image Scan Holdings soars despite taking revenue hit
Image Scan Holdings shares leapt on Thursday after the company said it expects to meet full year expectations despite disappointing first-half sales.
Feedback expects 'significant growth' in revenues
Medical imaging technology outfit Feedback expects to report significant growth in revenues throughout its current trading year.
Ixico revenues on track to meet full-year market expectations
Data analytics firm Ixico expects half-year revenues to be in line with market expectations.
NetScientific CEO stands down to assist with cost reduction efforts
NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.
AB Dynamics shares jump as six-month profits double
AB Dynamics nearly doubled its profits over the first half, even as it continued to expand its international footprint and invest for the future.
Sunrise Resources makes progress with various projects
Sunrise Resources updated the market on some of its projects on Wednesday, saying that at the CS Pozzolan-Perlite Project, the latest testwork showed “promise” for the production of premium-value super-coarse horticultural grades of perlite.
PetroNeft confirms new reserves in Cheremshanskoye field
Russia-focussed oil and gas exploration and production company PetroNeft updated the market on its 50%-owned licence 67 on Wednesday, reporting that new reserves had been approved for the licence in the Cheremshanskoye field.
Ixico signs on two new biopharmaceutical clients
Data analytics company Ixico has signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's disease (HD), and a phase 3 study in another rare neurological disease.
Diurnal gets orphan drug designation for Alkindi in Australia
Specialty pharmaceutical company Diurnal Group announced on Wednesday that its ‘Alkindi’ product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication ‘replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old’.
Metals Exploration emerges from quarter of change
Pacific Rim-focussed natural resources exploration and development company Metals Exploration updated the market on its Runruno gold project in the Philippines on Wednesday, reporting mining of 2. 93Mt in the quarter ended 31 March, with total ore mined standing at 573Kt.
Beximco gets FDA approval for generic anti-allergy drug
Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to ‘Periactin’ 4mg tablets from Merck and Company.
Mi-Pay revenue boosted by fraud management launch
Mi-Pay Group's shares edged upwards on Wednesday as the company reported a reduction in annual loss as revenue crept up following the launch of its new fraud management service.
Midatech Pharma mired in losses as R&D costs mount
Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.
Ascent Resources raises £750,000 in oversubscribed placing
Exploration and production outfit Ascent Resources completed an oversubscribed placing of 214. 2m ordinary shares on Wednesday.